Search

BELKIN Vision

DSLT's impact on laser as a first-line therapy is discussed with Prof. Ike Ahmed.

Iqbal Ike K. Ahmed, MD, FRCSC

Show Description +

Iqbal Ike K. Ahmed, MD, FRCSC, shares why he believes that direct selective laser trabeculoplasty (DSLT) breaks down barriers of traditional glaucoma treatment, highlighting advantages in both patient and physician experiences.

Posted: 2/23/2024

Keywords:

DSLT and the Impact on Laser-First

Up Next

WGC 2023: DSLT: First Feedback and Experiences in Europe

WGC 2023: DSLT: First Feedback and Experiences in Europe

I. Paul Singh, MD; and Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Physician Testimonials

Dr. Lai Ngai shares her experience with DSLT treating patients in a remote setting.

Dr. Lai Ngai shares her experience with DSLT treating patients in a remote setting.

Lai Ngai, MD

Prof Burkhard Dick talks about his experience with DSLT.

Prof Burkhard Dick talks about his experience with DSLT.

Prof. Burkhard Dick

Prof. Gus Gazzard shares his personal experience with DSLT.

Prof. Gus Gazzard shares his personal experience with DSLT.

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Dr.Erik Mertens shares his experience with DSLT within his private clinics.

Dr.Erik Mertens shares his experience with DSLT within his private clinics.

Erik L. Mertens, MD, FEBOphth

Prof. Sir Peng Khaw shares his personal experience with DSLT.

Prof. Sir Peng Khaw shares his personal experience with DSLT.

Professor Sir Peng Khaw

Talking to Your Patients about Laser-First

Dr. Paul Singh shares how he talks to his patients about laser as a first-line therapy.

Dr. Paul Singh shares how he talks to his patients about laser as a first-line therapy.

I. Paul Singh, MD

Prof. Ike Ahmed discusses how he talks to his patients about using laser as a first-line therapy.

Prof. Ike Ahmed discusses how he talks to his patients about using laser as a first-line therapy.

Ike Ahmed, MD, FRCSC

Dr. Tom Samuelson: How do you talk to your patients about laser first?

Dr. Tom Samuelson: How do you talk to your patients about laser first?

Thomas Samuelson, MD

Dr. Zak Vest shares how he talks to his patients about laser first.

Dr. Zak Vest shares how he talks to his patients about laser first.

Zachary Vest, MD

Prof. Gus Gazzard and how he talks to his patients about laser as a first-line therapy.

Prof. Gus Gazzard and how he talks to his patients about laser as a first-line therapy.

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

DSLT and the Impact on Laser-First

Prof. Gus Gazzard shares his thoughts on the potential impact DSLT will have in glaucoma care.

Prof. Gus Gazzard shares his thoughts on the potential impact DSLT will have in glaucoma care.

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Dr. Tom Samuelson discusses how DSLT could impact access to care.

Dr. Tom Samuelson discusses how DSLT could impact access to care.

Thomas Samuelson, MD

Dr. Zak Vest of Mile High Eye in Colorado shares what the thinks the potential is for DSLT.

Dr. Zak Vest of Mile High Eye in Colorado shares what the thinks the potential is for DSLT.

Zachary Vest, MD

DSLT's impact on laser as a first-line therapy is discussed with Prof. Ike Ahmed.

DSLT's impact on laser as a first-line therapy is discussed with Prof. Ike Ahmed.

Iqbal Ike K. Ahmed, MD, FRCSC

ASCRS 2024

WGC 2023: DSLT: First Feedback and Experiences in Europe

WGC 2023: DSLT: First Feedback and Experiences in Europe

I. Paul Singh, MD; and Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Back to All Videos

DSLT's impact on laser as a first-line therapy is discussed with Prof. Ike Ahmed.

Iqbal Ike K. Ahmed, MD, FRCSC

Iqbal Ike K. Ahmed, MD, FRCSC, shares why he believes that direct selective laser trabeculoplasty (DSLT) breaks down barriers of traditional glaucoma treatment, highlighting advantages in both patient and physician experiences.

Posted: 2/23/2024

Keywords:

DSLT and the Impact on Laser-First

About BELKIN Vision

BELKIN Vision is bringing real innovation to the glaucoma laser therapy space with Direct-SLT. The Eagle™ is automated, contactless, and efficient - a more accessible first-line glaucoma laser therapy for both doctors and patients. Visit us online:

Visit us online: belkin-vision.com

Follow BELKIN Vision

The BELKIN Vision Eagle™ is currently available for sale in the EU and the UK. It is 510(k) cleared in the United States but is not yet available for sale. The Eagle device is indicated for use in selective laser trabeculoplasty (SLT). Nothing herein is intended to promote an off-label use of the Eagle device. The Eagle device is not intended to treat, cure, prevent or mitigate any specific disease.